| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing hydrocortisone and miconazole in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone- and urea-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone- and lidocaine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone- and neomycin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing clorquinaldol and hydrocortisone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing gentamicin and hydrocortisone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing fusidic acid and hydrocortisone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Clotrimazole- and hydrocortisone-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Crotamiton- and hydrocortisone-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing econazole and hydrocortisone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only acetic acid and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Cinchocaine and hydrocortisone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Chloramphenicol and hydrocortisone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Clioquinol and hydrocortisone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only ciprofloxacin and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Benzoyl peroxide and hydrocortisone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only bacitracin and hydrocortisone and neomycin and polymyxin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
| Product containing only colistin and hydrocortisone and neomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
| Crotamiton and hydrocortisone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only clorquinaldol and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Clotrimazole and hydrocortisone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only econazole and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Diiodohydroxyquinoline and hydrocortisone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only dimeticone and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only hydrocortisone and oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydrocortisone and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only hydrocortisone and miconazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone and neomycin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone and neomycin and polymyxin B only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
| Fusidic acid and hydrocortisone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone and nystatin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only hydrocortisone and potassium hydroxyquinoline sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone and pramocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone and urea only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Gentamicin and hydrocortisone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Clioquinol and hydrocortisone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only crotamiton and hydrocortisone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Clorquinaldol and hydrocortisone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only hydrocortisone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Fusidic acid and hydrocortisone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only clotrimazole and hydrocortisone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only econazole and hydrocortisone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone and lidocaine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone and miconazole only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only hydrocortisone and neomycin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only hydrocortisone and oxytetracycline in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Hydrocortisone only product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydrocortisone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydrocortisone in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydrocortisone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only gentamicin and hydrocortisone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Ciprofloxacin and hydrocortisone only product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Hydrocortisone only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydrocortisone and urea in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely hydrocortisone (as hydrocortisone sodium phosphate) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Hydrocortisone 10 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Hydrocortisone 10 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrocortisone 5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrocortisone 5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely acetic acid 20 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely acetic acid 20 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely hydrocortisone 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrocortisone 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL ear solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL ear solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely hydrocortisone 2 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrocortisone 2 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Acetic acid and hydrocortisone only product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone and neomycin only product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Acetic acid- and hydrocortisone-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Diiodohydroxyquinoline and hydrocortisone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Diiodohydroxyquinoline 10 mg/mL and hydrocortisone 10 mg/mL cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Diiodohydroxyquinoline 10 mg/mL and hydrocortisone 10 mg/mL cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone and pramocaine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only hydrocortisone and neomycin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing diiodohydroxyquinoline and hydrocortisone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone- and neomycin-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone- and pramocaine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing hydrocortisone and neomycin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely clotrimazole 10 milligram/1 gram and hydrocortisone (as hydrocortisone acetate) 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone 2 mg/g and lidocaine hydrochloride 10 mg/g cutaneous spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Hydrocortisone 2 mg/g and lidocaine hydrochloride 10 mg/g cutaneous spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
| Crotamiton 100 mg/g and hydrocortisone 2.5 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Crotamiton 100 mg/g and hydrocortisone 2.5 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]